Jakub Neradil

8PUBLICATIONS
30CO-AUTHORS
Molecular targetsGenome structure and regulationPredictive and prognostic markersMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 04, 2024
Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traits.

Lucie Curylova, Iva Staniczkova Zambo, Jakub Neradil

|Nov 16, 2023
Mitoribosomal synthetic lethality overcomes multidrug resistance in MYC-driven neuroblastoma.

Karolina Borankova, Maria Krchniakova, Lionel Y W Leck

|Aug 12, 2022
Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors.

Silvia Paukovcekova, Maria Krchniakova, Petr Chlapek

|May 25, 2022
Serotonin limits generation of chromaffin cells during adrenal organ development.

Polina Kameneva, Victoria I Melnikova, Maria Eleni Kastriti

|Jan 11, 2022
Iron-Chelation Treatment by Novel Thiosemicarbazone Targets Major Signaling Pathways in Neuroblastoma.

Peter Macsek, Jan Skoda, Maria Krchniakova

|Jul 24, 2021
New Target for Precision Medicine Treatment of Giant-Cell Tumor of Bone: Sunitinib Is Effective in the Treatment of Neoplastic Stromal Cells with Activated PDGFRβ Signaling.

Michal Mahdal, Jakub Neradil, Peter Mudry

Pageof 2

Frequent Collaborators

6 joint publications

Renata Veselska

6 joint publications

Jan Skoda

3 joint publications

Maria Krchniakova

2 joint publications

Lucie Curylova